ATE541041T1 - Produktion von rekombinantem aav mit hohem titer - Google Patents
Produktion von rekombinantem aav mit hohem titerInfo
- Publication number
- ATE541041T1 ATE541041T1 AT03754869T AT03754869T ATE541041T1 AT E541041 T1 ATE541041 T1 AT E541041T1 AT 03754869 T AT03754869 T AT 03754869T AT 03754869 T AT03754869 T AT 03754869T AT E541041 T1 ATE541041 T1 AT E541041T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- recombinant aav
- raav
- high titre
- titre recombinant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/252,182 US7091029B2 (en) | 2002-09-23 | 2002-09-23 | High titer recombinant AAV production |
| PCT/US2003/030098 WO2004027048A2 (en) | 2002-09-23 | 2003-09-23 | High titer recombinant aav production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE541041T1 true ATE541041T1 (de) | 2012-01-15 |
Family
ID=31992891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03754869T ATE541041T1 (de) | 2002-09-23 | 2003-09-23 | Produktion von rekombinantem aav mit hohem titer |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7091029B2 (de) |
| EP (1) | EP1546343B1 (de) |
| AT (1) | ATE541041T1 (de) |
| AU (1) | AU2003272672B2 (de) |
| CA (1) | CA2499386C (de) |
| ES (1) | ES2378883T3 (de) |
| NZ (1) | NZ562881A (de) |
| WO (1) | WO2004027048A2 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070202587A1 (en) * | 2002-09-23 | 2007-08-30 | Applied Genetic Technologies Corporation | Recombinant AAV production in mammalian cells |
| CA2713338C (en) | 2008-01-29 | 2021-10-26 | Applied Genetic Technologies Corporation | Recombinant virus production using mammalian cells in suspension |
| US11299715B2 (en) | 2013-01-08 | 2022-04-12 | Genzyme Corporation | Use of iNOS inhibitors to increase viral yield in culture |
| WO2015031686A1 (en) * | 2013-08-30 | 2015-03-05 | Amgen Inc. | High titer recombinant aav vector production in adherent and suspension cells |
| JP6635942B2 (ja) * | 2014-04-15 | 2020-01-29 | アプライド ジェネティック テクノロジーズ コーポレイション | 網膜色素変性症ｇｔｐアーゼレギュレーター（ｒｐｇｒ）をコードするコドン最適化核酸 |
| JP6204582B2 (ja) * | 2014-05-15 | 2017-09-27 | 高砂電気工業株式会社 | マイクロ蠕動ポンプ |
| EP3978614A3 (de) | 2015-01-07 | 2022-07-27 | Universitat Autònoma de Barcelona | Einzelvektor-genkonstrukt mit insulin und glucokinasegenen |
| US10610606B2 (en) | 2018-02-01 | 2020-04-07 | Homology Medicines, Inc. | Adeno-associated virus compositions for PAH gene transfer and methods of use thereof |
| EP3755795A4 (de) | 2018-02-19 | 2022-07-20 | Homology Medicines, Inc. | Adeno-assoziierte viruszusammensetzungen zur wiederherstellung der f8-genfunktion und verfahren zur verwendung davon |
| GB201806333D0 (en) * | 2018-04-18 | 2018-05-30 | Glaxosmithkline Ip Dev Ltd | Parvovirus vector production |
| WO2020154607A1 (en) * | 2019-01-25 | 2020-07-30 | Biogen Ma Inc. | Seed culture process for aav production |
| SG11202110607WA (en) | 2019-04-01 | 2021-10-28 | Tenaya Therapeutics Inc | Adeno-associated virus with engineered capsid |
| US20220307055A1 (en) * | 2019-08-28 | 2022-09-29 | University Of Florida Research Foundation, Incorporated | Improved production of recombinant aav using embryonated avian eggs |
| TW202140791A (zh) | 2020-01-13 | 2021-11-01 | 美商霍蒙拉奇醫藥公司 | 治療苯酮尿症之方法 |
| TW202208632A (zh) | 2020-05-27 | 2022-03-01 | 美商同源醫藥公司 | 用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法 |
| US20230407329A1 (en) | 2020-11-20 | 2023-12-21 | University Of Florida Research Foundation, Incorporated | Improved aav production using potassium chloride |
| CA3218362A1 (en) * | 2021-04-27 | 2022-11-03 | Novartis Ag | Viral vector production system |
| TW202404993A (zh) | 2022-04-11 | 2024-02-01 | 美商特納亞治療股份有限公司 | 具經工程化蛋白殼之腺相關病毒 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2626383B1 (fr) * | 1988-01-27 | 1991-10-25 | Commissariat Energie Atomique | Procede de microscopie optique confocale a balayage et en profondeur de champ etendue et dispositifs pour la mise en oeuvre du procede |
| US6686200B1 (en) * | 1993-08-31 | 2004-02-03 | Uab Research Foundation | Methods and compositions for the large scale production of recombinant adeno-associated virus |
| US5965441A (en) | 1996-11-13 | 1999-10-12 | The General Hospital Coporation | HSV/AAV hybrid amplicon vectors |
| GB9721909D0 (en) * | 1997-10-17 | 1997-12-17 | Cantab Pharma Res | Gene delivery vectors and their uses |
| US7258858B2 (en) * | 1997-12-24 | 2007-08-21 | University Of Guelph | Method of identifying high immune response animals |
| WO2000011149A1 (en) * | 1998-08-24 | 2000-03-02 | Uab Research Foundation | Methods of producing high titer recombinant adeno-associated virus |
| WO2000016799A1 (en) * | 1998-09-23 | 2000-03-30 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods of treating chronic pain |
| US7060497B2 (en) * | 2000-03-03 | 2006-06-13 | The Board Of Trustees Of The Leland Stanford Junior University | Adeno-associated viral vector-based methods and compositions for introducing an expression cassette into a cell |
-
2002
- 2002-09-23 US US10/252,182 patent/US7091029B2/en not_active Expired - Lifetime
-
2003
- 2003-09-23 CA CA2499386A patent/CA2499386C/en not_active Expired - Lifetime
- 2003-09-23 WO PCT/US2003/030098 patent/WO2004027048A2/en not_active Application Discontinuation
- 2003-09-23 EP EP03754869A patent/EP1546343B1/de not_active Expired - Lifetime
- 2003-09-23 NZ NZ562881A patent/NZ562881A/en not_active IP Right Cessation
- 2003-09-23 AT AT03754869T patent/ATE541041T1/de active
- 2003-09-23 ES ES03754869T patent/ES2378883T3/es not_active Expired - Lifetime
- 2003-09-23 AU AU2003272672A patent/AU2003272672B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004027048A2 (en) | 2004-04-01 |
| WO2004027048A3 (en) | 2004-07-15 |
| NZ562881A (en) | 2009-07-31 |
| EP1546343A4 (de) | 2007-12-19 |
| AU2003272672B2 (en) | 2006-04-06 |
| ES2378883T3 (es) | 2012-04-18 |
| EP1546343A2 (de) | 2005-06-29 |
| CA2499386C (en) | 2014-12-09 |
| CA2499386A1 (en) | 2004-04-01 |
| AU2003272672A1 (en) | 2004-04-08 |
| EP1546343B1 (de) | 2012-01-11 |
| US7091029B2 (en) | 2006-08-15 |
| US20040058439A1 (en) | 2004-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE541041T1 (de) | Produktion von rekombinantem aav mit hohem titer | |
| ES2664505T3 (es) | Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas | |
| CY1124586T1 (el) | Ομαδες, αλληλουχιες, φορεις αδενο-σχετιζομενου ιου (aav) που περιεχουν αυτον, και οι χρησεις τους | |
| CY1121446T1 (el) | Αλληλουχιες αδενο-σχετιζομενου ιου (aav) οροτυπου 8, φορεις που περιεχουν αυτες και χρησεις για αυτους | |
| WO2003018820A3 (en) | Mutant recombinant adeno-associated viruses related applications | |
| WO2002053703A3 (en) | Aav2 vectors and methods | |
| ATE454393T1 (de) | Egvii-endoglucanase und dafür codierende nukleinsäuren | |
| AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
| HUP0004639A2 (hu) | Chlamydia fehérje, génszekvencia és ezek alkalmazása | |
| WO2004112831A3 (en) | High titer recombinant influenza viruses for vaccines and gene therapy | |
| CY1112140T1 (el) | Ανασυνδυασμενοι ιοι γριππης για εμβολια και γονιδιακη θεραπεια | |
| AU2002305450A1 (en) | Proteomimetic compounds and methods | |
| HUP0202442A2 (hu) | Több citokinből és ellenanyagból álló komplexek | |
| HK1080517A1 (en) | Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use | |
| CY1106815T1 (el) | Αλληλουχιες νουκλεινικου οξεος του αδενοσχετιζομενου ιου του οροτυπου 1 και φορεις και κυτταρα ξενιστες περιεχοντας αυτες | |
| MXPA03010103A (es) | Peptidos y composiciones anti-microbianos. | |
| WO2002024234A3 (en) | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye | |
| CY1110868T1 (el) | Ελαχιστη αλληλουχια dna που δρα ως μονωτης της χρωματινης και η χρηση της στην πρωτεϊνικη εκφραση | |
| BRPI0411363A (pt) | seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas | |
| WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
| CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
| FR2837098B1 (fr) | Composition cosmetique ou pharmaceutique comprenant des peptides, procedes de traitement et utilisations | |
| ATE551069T1 (de) | Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung | |
| EP2278020A3 (de) | Antikörpergentransfer und rekombinantes AAV dafür | |
| EP1071443A4 (de) | Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen |